At close: January 3 at 5:31:23 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-17,612.0000
-17,612.0000
-24,126.0000
-35,718.0000
-18,254.0000
Investing Cash Flow
8,695.0000
8,695.0000
-7,999.0000
-30,262.0000
3,005.0000
Financing Cash Flow
4,050.0000
4,050.0000
6,417.0000
67,689.0000
58,200.0000
End Cash Position
14,556.0000
14,556.0000
19,237.0000
44,761.0000
43,154.0000
Capital Expenditure
-446.0000
-446.0000
-521.0000
-13,708.0000
--
Issuance of Capital Stock
5,094.0000
5,094.0000
7,111.0000
76,088.0000
58,334.0000
Issuance of Debt
--
--
--
--
500.0000
Repayment of Debt
-550.0000
-550.0000
-471.0000
-5,366.0000
--
Free Cash Flow
-18,058.0000
-18,058.0000
-24,647.0000
-49,426.0000
-18,254.0000
12/31/2020 - 8/26/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SANN.SW Santhera Pharmaceuticals Holding AG
14.46
+4.63%
IDIA.SW Idorsia Ltd
0.9790
+19.10%
MOLN.SW Molecular Partners AG
4.4300
+9.11%
NWRN.SW Newron Pharmaceuticals S.p.A.
8.81
-1.56%
NRXPW NRx Pharmaceuticals, Inc.
0.3500
+84.21%
BSLN.SW Basilea Pharmaceutica AG
41.50
+0.36%
EVE.SW Evolva Holding SA
1.0900
+21.11%
HALB Halberd Corporation
0.0041
+5.13%
22UA.DE BioNTech SE
112.60
-0.18%
IMU.AX Imugene Limited
0.0390
0.00%